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Activity-based protein profiling has emerged as a powerful tool for 
visualizing glycosidases in complex biological samples. Several 
configurational cyclophellitol isomers have been shown to display 
high selectivity as probes for glycosidases processing substrates 
featuring the same configuration. Here, a set of deoxygenated 
cyclophellitols are presented which enable inter-class profiling of 
β-glucosidases and β-galactosidases. 
Glycosidases are hydrolytic enzymes that catalyze the 
hydrolysis of oligosaccharides and glycoconjugates.
1
 
Glycosidases are involved in a broad array of human 
pathologies and are therefore promising therapeutic targets.
2
 
Activity-based protein profiling (ABPP) provides an effective 
tool for the analysis of enzyme composition, expression and 
activity, and can assist in the discovery of enzyme inhibitors.
3
 
ABPP relies on the addition of a mechanism-based inhibitor to 
the sample of interest, which reacts with the catalytic 
machinery of the target enzyme in a covalent and irreversible 
manner. The inhibitor carries a reporter tag and is termed an 
activity-based probe (ABP). As the first example on the 
development of ABPP, Cravatt and co-workers have described 
irreversible fluorophosphonate based ABPs which display high 
reactivity towards a wide range of serine hydrolases (SH).
4
 
These ABPs were used to reveal active SH composition and 
expression level in various tissues, and as well in the 
development of highly specific and potent inhibitors against, 
for instance, monoacylglycerol lipase in a competitive ABPP 
setting.
5
 Cyclophellitol (1, Fig. 1), first isolated from Phellinus 
sp. is a covalent irreversible retaining β-glucosidase inhibitor.
6
 
The configurational isomers, galacto-cyclophellitol (2)
7
 and 
manno-cyclophellitol (3)
8
 are inactivators for β-galactosidases 
and β-mannosidases, respectively, and their selectivity arises 
from their absolute configurations. We have previously 
reported several cyclophellitol based ABPs for selective 
glycosidase profiling.
9–11
 For example, treatment of mouse 
tissue lysates with acyl ABP 4 resulted in tissue-specific 
fluorescent labelling of the three retaining β-
glucocerebrosidases (GBA1, 2 and 3) and lactase-phlorizin 
hydrolase (LPH) without non-specific cross-labelling. Later 
studies revealed that alkyl ABP 5 also effectively labels these 
retaining β-glucosidases.
12
 While the selectivity of these 
probes is an attractive value, it also impedes the study of 
multiple enzyme classes with a single probe, as for example 
can be done by the broad-spectrum SH ABPs developed by 
Cravatt and co-workers.
4
 Therefore, the development of broad 
spectrum glycosidase ABPs would be of interest. Since the 
substrate specificity of glucosidases, mannosidases and 
galactosidases is dependent on the carbohydrate hydroxyl 
configuration at C2 and C4 (axial or equatorial), removal of 
these alcohols may abolish active site preference. We 
therefore synthesized four deoxygenated ABPs 6-9 and we set 
out to establish whether these compounds would be effective 
Fig. 1. (a) Structures of cyclophellitols 1-3, selective covalent and irreversible retaining 
glycosidase inhibitors. (b) Selective β-glucosidase ABPs 4-5, 4-deoxy ABPs 6-7 and 2,4-
deoxy ABPs 8-9. 
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ABPs indiscriminate towards glucosidases and galactosidases 
(and for 8-9, mannosidases). 
The synthesis of compounds 6-9 was achieved from key-
intermediates 12 and 15, which were prepared as follows. The 
primary alcohol in diol 10 (available by chemistry developed by 
Madsen and co-workers, Scheme 1a)
13
 was protected as the p-
methoxybenzyl ether (PMB) after which tosylation of the 
secondary alcohol afforded intermediate 11. Treatment of 11 
with lithium aluminum hydride followed by deprotection 
afforded 12. For cyclohexene 15 (Scheme 1b), chiral aldehyde 
13 (available by chemistry developed by Helmchen and co-
workers)
14
 was asymmetrically allylated using Brown’s reagent 
and subsequently subjected to ring-closing metathesis using 
the Grubbs 2
nd
 generation catalyst to give 14. Benzoylation 
and detritylation afforded cyclohexene 15. Both cyclohexenes 
12 and 15 could be reacted with trichloroacetonitrile to afford 
the corresponding primary imidates (Scheme 1c), which upon 
treatment with N-iodosuccinimide (NIS) cyclized to afford the 
cyclic imidates 16 and 19 stereospecifically. Acidolysis and 
base treatment resulted in formation of aziridines 17 and 20, 
which were alkylated with an azidoalkyl spacer and 
deprotected to give alkyl aziridines 18 and 21, and then ligated 
with a reporter tag using click chemistry to afford 
deoxygenated ABPs 6-9 (see ESI). 
The labelling efficiency and specificity towards recombinant β- 
glucosidases, β-galactosidases and β-mannosidases was 
investigated for fluorescent ABPs 6 and 8, and compared to 
that of β-glucosidase selective probe 5. After enzyme 
incubation with a range of ABP concentrations (30 minutes, 37 
°C, optimal enzyme pH), recombinant Homo sapiens GBA1 is 
highly efficiently labelled by ABP 5, with protein bands 
visualized at probe concentrations as low as 10 nM (Fig. 2a). 
Additionally, 4-deoxy ABP 6 also labelled GBA1 efficiently, 
although the potency was slightly reduced, likely due to lacking 
hydrogen-bonding interactions within the active site residue(s) 
as the result of the absence of OH-4. The labelling potency of 
2,4-deoxy ABP 8 proved to be drastically reduced. All bands 
could be competed with selective β-glucosidase inactivator 1. 
Also, denatured enzyme (1% SDS, 100 °C, 5 min) is not labelled 
by any of the probes indicating that all labelling is activity-
based. As expected, binding kinetics studies revealed that 5 is 
a far more potent GBA1 inactivator (kinact/KI = 27.51 ± 0.85 µM
-
1
min
-1
) than 6 (kinact/KI = 0.14 ± 0.08 µM
-1
min
-1
). Kinetic 
parameters for 8 could not be determined under our assay 
conditions reflecting its low potency. Labelling of Cellvibrio 
japonicus β-galactosidase from glycoside hydrolase family 35 
(CjGH35A)
15
 could be detected at micromolar concentrations 
of 5 and 8. Interestingly, 4-deoxy ABP 6 was significantly more 
potent and labelled the enzyme at concentrations down to 100 
nM, similar to GBA1 labelling; which is surprising given the 
extensive interactions of O-4, from a galacto-cyclophellitol 
aziridine, with the enzyme (see ESI). Indeed, kinetic 
parameters for 6 in CjGH35A (kinact/KI = 0.16 ± 0.07 µM
-1
min
-1
) 
are comparable to that in GBA1 (kinetic parameters of 5 and 8 
could not be determined under our assay conditions, due to 
low potency). Competition experiments indicated the labelling 
was activity-based, although full competition was not achieved 
which could indicate a fraction of non-specific binding. Lastly, 
we found that none of the ABPs showed significant labelling of 
GH2 β-mannosidase from Helix pomatia (see ESI). Indeed, it is 
known that OH-2 is highly important for coordination to the 
glycosidase catalytic nucleophile and stabilizing the transition 
state (TS).
16
 Moreover, probes 5, 6 and 8 mimic preferentially 
adopt a 
4
H3 configuration, which is characteristic for β-
glucosidase and β-galactosidase transition states, whereas β-
mannosidases often favour a B2,5 TS.
17
 Next, the glycosidase 
profiling by probes 6 and 8 in lysates from mouse (C57bl/6j, 
Jackson’s laboratories) kidney and liver tissue, and human 
wild-type fibroblast cells (Lonza) was investigated, and 
compared to that of β-glucosidase selective probe 5. The 
samples were incubated with the ABPs under identical 
Fig. 2. Fluorescent labelling of recombinant H. sapiens GBA1 and C. japonicus β-
galactosidase with ABPs 5, 6 and 8 (left panel), and competition experiments with 
selective cyclophellitol inhibitors 1 or 2 (right panel). (a) GBA1 is potently labelled by 5 
and 6, but not 8. All labelling was activity-based, indicated by competition experiments 
with GBA1 selective inhibitor 1. (b) β-galactosidase is potently labelled by 5, in an
activity-based fashion. 
Scheme 1 The synthesis of deoxygenated ABPs required two different synthetic 
strategies (a and b) to afford key intermediates 12 and 15, which were further 
functionalized to ABPs 6-9 following similar synthetic transformations (c). Reagents 
and conditions i) PMBCl, 2-aminoethyl diphenylborinate (10 mol%), K2CO3, KI, MeCN, 
60 °C, 95%; ii) TsCl, pyridine, 60 °C, 90%; iii) LiAlH4, THF, reflux, 86%; iv) HCl (10 %), 
DCM/HFIP, 86%; v) 1. (+)-Ipc2B(allyl)borane, THF, -90 °C; 2. Grubbs II (5 %), DCM, 
reflux, 77%, dr 86:14; vi) BzCl, Et3N, DMAP, DCM, 84%; vii) CSA, MeOH, DCM, 94%. 
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conditions (1 µM ABP, pH 5.0, 37 °C, 30 min). In mouse liver 
lysates, 5 labels a distinct band at ~65 kDa (Fig. 3a), 
corresponding to the molecular weight of GBA1 (58 - 66 
kDa
18
), and this band is fully abolished when the sample was 
pre-incubated with GBA1 specific inhibitor 1.
19
 Similarly, 
incubation with 6 resulted in a band at the same height. This 
band could only be partially competed with 1, and pre-
incubation by specific β-galactosidase inactivator 2 resulted in 
partial competition as well. Ultimately, full competition was 
achieved by pre-incubation with both cyclophellitols 1 and 2. 
Thus, in contrast to labelling with 5, it was concluded that 
incubation with 6 resulted in the concomitant labelling of 
GBA1 and a β-galactosidase, presumably acid β-galactosidase 
(GLB1, ~63 kDa).
20
 To identify the bands labelled on gel, the 
proteins were enriched by incubation of the lysate with biotin 
probe 7 and subsequent pull-down with streptavidin beads. 
After tryptic digestion, the peptide fragments were identified 
by LC-MS/MS and the abundance of the protein hits was 
quantified as previously described,
21
 in unsupervised mode 
using the default settings of the PLGS (Waters) and IsoQuant 
software. Indeed, incubation with 7 resulted in enrichment of 
GBA1 and GLB1, corresponding to the mixed band at ~65 kDa 
on gel. In contrast, labelling with ABP 8 did not result in 
labelling of GBA1 or GLB1. Multiple bands were visible on gel, 
but no competition was observed except for one band at ~115 
kDa of an unknown protein. We therefore conclude that the 
other bands were a result of non-specific binding. Regardless, 
the lysate was incubated with 9 and the labelled proteins were 
identified by proteomic analysis. Whereas no enrichment of 
GBA1 could be detected, the probe did show increased levels 
of GLB1 labelling. Additionally, LC-MS/MS analysis detected 
enrichment of β-galactosylceramidase (GALC), an 80 kDa 
protein which is processed in the lysosomes into two 
catalytically active subunits of ~30 and ~50 kDa,
22
 and is 
responsible for the hydrolysis of galactosylceramide. 
Interestingly, fluorescent labelling with 8 did not identify GALC 
on gel. However, it is known that expression levels of GALC in 
the liver are low.
23
 
In mouse kidney lysates (Fig. 3b), 5 only labels GBA1 minimally. 
In contrast, bands at ~65 kDa and ~45 kDa were observed with 
probe 6 which could be fully competed out by pre-incubation 
with 2, but not 1. This indicated the labelling of mainly β-
galactosidases in this sample, presumably GLB1 and GALC, 
which was subsequently confirmed by proteomics experiments 
as described above. Enrichment of GBA1 was also detected but 
less pronounced, in line with the fluorescent assay. Labelling 
with probe 6 was also observed for GLB1-like protein 1 (GLB1l, 
~68 kDa) and 2 (GLB1l2, processed mass unknown), which 
both possess the GLB1 active site motif.
24
 While 2,4-deoxy ABP 
8 did not significantly label GBA1 or GLB1, proteomics 
identified GLB1 and GLB1l2 by pull-down with 9. Interestingly, 
a strong band at ~45 kDa was labelled, which could be 
competed with 2. Indeed, proteomics revealed increased 
labelling of GALC by this probe and it was therefore concluded 
that 8 is a GALC specific ABP.  
Lastly, the labelling of human fibroblast lysates was 
investigated (Fig. 3c). A pattern of bands between 55-70 kDa is 
labelled by 5 which can subsequently be fully competed for 
with 1, indicating the labelling of different isoforms
18
 of GBA1 
in this lysate. Similarly, 6 labels bands between 55-70 kDa, 
however with increased signal intensity. Approximately 50% 
competition was achieved by pre-incubation with either 1 or 2, 
whereas pre-incubation with both inhibitors completely 
abrogated labelling. Indeed, pull-down analysis identified both 
GBA1 and GLB1 enrichment by probe 7. Finally, 8 did not show 
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Fig. 3 Fluorescent labelling of mouse liver (a), kidney (b) and human fibroblast (c) 
lysates with probes 5, 6 and 8, complemented with competition experiments with β-
glucosidase specific covalent inhibitor 1 and β-galactosidase specific 2. The bar charts 
display the LC-MS/MS pull-down analyses with the biotinylated ABP analogues 
corresponding to the gels on the left, compared to the negative control (DMSO). (a)
Probe 5 only labels GBA1, while 6 labels GBA1 and GLB1, and 8 only shows non-specific
labelling of proteins in gel, although pull-down analysis shows enrichment of GLB1 and 
GALC with 9. (b) Only low amounts of GBA1 could be detected by specific probe 5. 4-
Deoxy probe 6 labels GBA1, GLB1 (like) protein and GALC. ABP 8 shows specific 
fluorescent labelling of GALC on gel. (c) ABP 5 labels GBA1 only, while 6 labels both 
GBA1 and GLB1. ABP 8 does not significantly label proteins, however pull-down analysis 
shows enrichment of GLB1. 
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significant labelling of proteins in the sample, whereas GLB1 
was enriched by ABP 9 according to LC-MS/MS analysis. 
In summary, we have developed syntheses towards a set of 
deoxygenated probes which were modelled on cyclophellitol 
aziridine 5. None of the probes display activity towards β-
mannosidases. Deoxygenation at C2 and C4 (ABPs 8-9) enables 
labelling of purified β-glucosidases and β-galactosidases, albeit 
with low potency. Nevertheless, it was found that 8 displayed 
unexpected specificity towards β-galactosylceramidase in 
mouse kidney lysate where the enzyme is abundant.
23
 
Deoxygenation at C4 (ABPs 6-7) affects the binding kinetics for 
GBA1, however in vitro labelling proceeded with high 
efficiency and moreover these probes now identify retaining β-
galactosidases as well. Based on the results presented herein 
we conclude that, indeed, probes designed for simultaneously 
profiling retaining glycosidases processing differently 
configured glycosides are within reach. We had earlier 
observed that probes designed for a specific class of retaining 
glycosidases may possess cross-reactivity towards other 
glycosidases,
10
 however these results could not be predicted. 
Here, we show that by substitution of the hydroxyl group that 
distinguishes glucose from galactose for hydrogen on an 
otherwise unaltered cyclophellitol aziridine yields probes 
labelling both glucosidases and galactosidases. The strategy is 
however not general, since stripping off OH-2 yields a largely 
inactive probe. Future research on differently configured, OH-
deleted cyclophellitol aziridines is required to establish if and 
to what extent this strategy is viable to deliver a set of broad-
spectrum glycosidase ABPs, for use in combination with the 
specific exo-glycosidase probes already in hand for dissecting 
large numbers of retaining glycosidases from various species. 
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